Idexx Laboratories Brings LNA Technology To Veterinary Diagnostics

Exiqon allows Idexx to start implementing LNA technology.

Exiqon today announced that it granted a non-exclusive license to Idexx Laboratories, Inc., to use Locked Nucleic Acid (LNA) technology in products for veterinary diagnostics. LNA provides unique characteristics to molecular assays and offers many possibilities for developing competitive products.

Exiqon will receive upfront, milestones and royalty payments on global sales of the products covered by this agreement. Financial terms of the agreement were not disclosed.

“We are pleased to see Idexx Laboratories has chosen to apply Exiqon's proprietary technology in the field of veterinary diagnostics,” says Lars Kongsbak, CEO and president of Exiqon. “We are excited that the LNA technology is now being applied in veterinary diagnostic products which emphasizes the broad applicability of the LNA technology.”


Leave a Comment


Your email address will not be published. Required fields are marked *



Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.